We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: The AccuSpan HCV RNA linearity panel (Photo courtesy of SeraCare).
Image: The AccuSpan HCV RNA linearity panel (Photo courtesy of SeraCare).
SeraCare Life Sciences (Milford, MA, USA) promoted its new AccuSpan HCV RNA Linearity Panel at the 70th AACC Annual Scientific Meeting and Clinical Lab Expo held in Chicago, USA from July 29 - August 2.

SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. The company supports the diagnostic testing industry with biological materials to develop, validate, and challenge today's most trusted serology and molecular infectious disease assays. With recent rapid advances in clinical genomics and precision diagnostics, SeraCare has developed a leading portfolio of highly flexible, patient-like reference materials and lab QC programs to support advanced diagnostic applications such as next-generation sequencing and digital PCR.

At AACC 2018, SeraCare promoted its new AccuSpan HCV RNA Linearity Panel, a safe, non-infectious panel that is compatible with leading PCR-based applications and features eight members in K3EDTA plasma. The eight-member panel is made from serial dilutions of high titer recombinant Hepatitis C virus (genotype 1b) with established reactivity for HCV RNA and one negative member. The panel consists of seven members representing serial log dilutions of AccuPlex recombinant HCV in negative diluent and one negative member prepared from the diluent. The diluent was prepared from pooled K3EDTA plasma that was filtered through a 0.2 micron filter with sodium azide (0.09%) added as a preservative.

The panel can be used for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, verifying lot changes, performing linearity studies, or whenever there are indications of possible assay deterioration.

Related Links:
SeraCare Life Sciences

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Pathology

view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more

Industry

view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.